[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@Carl_T_Therapy Carl T. Therapy
Carl T. Therapy posts on X about $okur the most. They currently have XXX followers and XX posts still getting attention that total XX engagements in the last XX hours.
Engagements: XX #
- X Week XXX -XX%
- X Months XXXXX -XX%
- X Year XXXXXX -XX%
Mentions: X #
- X Month X no change
- X Months X -XX%
- X Year XX +20%
Followers: XXX #
- X Month XXX +3.90%
- X Months XXX +25%
- X Year XXX +20%
CreatorRank: undefined #
Social Influence #
Social topic influence $okur
Top Social Posts #
Top posts by engagements in the last XX hours
"$OKUR Alpelisib QD covers EC80 PI3Ka for 16/24h It gets monotx responses in mBC (8%) and a mPFS of 5.8mo (where PFS is what actually matters in BC) OKI-219 900mg covers EC80 for 10/12h (BID dosing) Therefore it should get monotx responses 2024 SABCS update only had n=2 patients at 300mg dose with follow-up beyond XX days no patients out beyond XX days at either XXX or 900mg - kinetics of responses in mBC typically slower than other indications XXX is exceptionally clean - G1 AEs only at 900mg mBC is about combo therapy - so cleanliness is next godliness n=70 patients dosed with data update 4Q"
X Link @Carl_T_Therapy 2025-10-27T22:13Z XXX followers, XXX engagements